Endodiag

Primary contact
Pépinière Paris Santé Cochin
29 rue du Faubourg Saint Jacques
75014 Paris
France
Pépinière Paris Santé Cochin
29 rue du Faubourg Saint Jacques
75014 Paris
France
Funding 💰
Total $9.1M
Select investors Karista, Medevice, CM-CIC, BNP Paribas Développement
Key people 🧑🤝🧑
- Cécile Real - Co-founder & CEO
- Jean Bouquet de la Jolinière - Co-founder & Medical Advisor
- Jean Gogusev - Co-founder & Scientific Advisor
- Patrick Henri - Co-founder & Sales & Marketing Advisor
- Marc Essodaigui - VP Corporate Development
- Karine Mignon Godefroy - VP R&D
Highlights ⭐
- Solving a problem: Although endometriosis is a major cause of subfertility (40% of affected patients are infertile) and chronic pain, it takes an average of 8 to 10 years between the onset of the disease and its diagnosis, currently only achieved through surgery.
- Riding the wave: Endodiag is part of the global femtech industry, which is expected to grow at a CAGR of 13% from 2021 to 2026.
- Big addressable market: Endometriosis affects 10% of women of reproductive age or over 180 million patients worldwide.
- Scientific co-founders: The company leverages the experience of its scientific cofounders who have been working in this field for over 20 years.
Video ▶️
Awards & Recognitions 🏆
Last update: January 13, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more